The asparaginyl-tRNA synthetase-like SlgZ and methyltransferase SlgM enzymes are involved in the biosynthesis of the tetramic acid streptolydigin in Streptomyces lydicus . Inactivation of slgZ led to a novel streptolydigin derivative. Overexpression of slgZ , slgM , or both in S. lydicus led to a considerable increase in streptolydigin production.
Biosynthesis of the hybrid polyketide-nonribosomal peptide antibiotic streptolydigin, 3-methylaspartate, is utilized as precursor of the tetramic acid moiety. The three genes from the Streptomyces lydicus streptolydigin gene cluster slgE1-slgE2-slgE3 are involved in 3-methylaspartate supply. SlgE3, a ferredoxin-dependent glutamate synthase, is responsible for the biosynthesis of glutamate from glutamine and 2-oxoglutarate. In addition to slgE3, housekeeping NADPH-and ferredoxin-dependent glutamate synthase genes have been identified in S. lydicus. The expression of slgE3 is increased up to 9-fold at the onset of streptolydigin biosynthesis and later decreases to ϳ2-fold over the basal level. In contrast, the expression of housekeeping glutamate synthases decreases when streptolydigin begins to be synthesized. SlgE1 and SlgE2 are the two subunits of a glutamate mutase that would convert glutamate into 3-methylaspartate. Deletion of slgE1-slgE2 led to the production of two compounds containing a lateral side chain derived from glutamate instead of 3-methylaspartate. Expression of this glutamate mutase also reaches a peak increase of up to 5.5-fold coinciding with the onset of antibiotic production. Overexpression of either slgE3 or slgE1-slgE2 in S. lydicus led to an increase in the yield of streptolydigin.The vast majority of antibiotic and antitumor drugs belong either to the polyketide or the nonribosomal families of natural products. A related family comprises hybrid compounds containing polyketide and nonribosomal peptide moieties. Their biosynthesis involves the participation of a modular polyketide synthase (PKS) for the condensation of acyl coenzyme A (acylCoA) precursors and a nonribosomal peptide synthetase (NRPS) that condenses amino acids after their activation to an aminoacyl-AMP precursor. Both type I PKSs and NRPSs are multifunctional enzymes that are organized into modules and use a similar strategy for the assembly of these short carboxylic and amino acid building blocks. The minimal set of domains in a type I PKS includes ketosynthase (KS), acyltransferase, and acyl-carrier protein activities responsible for the catalysis of one cycle of polyketide chain elongation. These PKS modules can contain further domains such as ketoreductase (KR), dehydratase (DH), or enoylreductase to reduce the keto groups generated during the condensation process (9). In a similar way, a typical minimal NRPS module consists of condensation, adenylation, and peptidyl carrier protein (PCP) domains (9).Streptolydigin (compound 1) (Fig. 1) is an inhibitor of bacterial RNA polymerase -subunit produced by Streptomyces lydicus (27, 29) and a potent inhibitor of eukaryotic DNA polymerase terminal deoxynucleotidyltransferase (6, 7). The streptolydigin biosynthetic gene cluster has been isolated and characterized from the producer organism (21). Streptolydigin belongs to the hybrid polyketide-nonribosomal peptide family of natural products. The streptolydigin type I PKS, composed of one loading domain and seven extension module...
Summary Two genes of the streptolydigin gene cluster in Streptomyces lydicus cluster encode putative family 16 glycoside hydrolases. Both genes are expressed when streptolydigin is produced. Inactivation of these genes affects streptolydigin production when the microorganism is grown in minimal medium containing either glycerol or d‐glucans as carbon source. Streptolydigin yields in S. lydicus were increased by overexpression of either slgC1 or slgC2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.